The effects of the glycaemic control on the severity of the delirium in the advanced phase of Alzheimer's disease

F1000Res. 2020 Dec 16:9:1470. doi: 10.12688/f1000research.26022.2. eCollection 2020.

Abstract

Background: Behavioral and psychological symptoms of dementia (BPSD) and delirium are common in advanced phases of Alzheimer's disease (AD).

Methods: Thirty-eight moderate-severe AD patients were enrolled (n=16 affected by type 2 diabetes). Each patient received a comprehensive geriatric assessment (CGA) (including evaluation of BPSD and frailty), and a complete metabolic evaluation (including the measurement of the glycated hemoglobin, HbA1c).

Results: Both the hyper- and hypo-glycemic extremes of the glycemic spectrum worsened BPSD, but delirium was more susceptible to hypoglycemic events. The severity of delirium was significantly related to cognitive function (r = -0.585, p<0.001) and frailty (r = +0.440, p<0.05).

Conclusions: The measurement of HbA1c was useful for evaluating the risk of delirium in relationship to glycemic control and nutritional status.

Keywords: Alzheimer’s disease; Marigliano-Cacciafesta-polypathology-scale; delirium; glycaemic control.

MeSH terms

  • Aged
  • Alzheimer Disease* / complications
  • Delirium*
  • Diabetes Mellitus, Type 2* / complications
  • Glycemic Control
  • Humans

Grants and funding

The author(s) declared that no grants were involved in supporting this work.